Arcadia Investment Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Arcadia Investment Management’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,750	Closed	-$8K	–	326
2019 Q1	$8K	Hold	1,750	–	–	﹤0.01%	269
2018 Q4	$6K	Hold	1,750	–	–	﹤0.01%	263
2018 Q3	$18K	Hold	1,750	–	–	﹤0.01%	281
2018 Q2	$13K	Buy	+1,750	New	+$12.2K	﹤0.01%	303

Other funds holding INSY

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Arcadia Investment Management's INSY Position: Q2 2019 in Review

Arcadia Investment Management sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 1,750 shares — an estimated $8K sold.

Arcadia Investment Management first reported a position in INSY in Q2 2018 and held it in 4 quarters. The position peaked at $18K in Q3 2018. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

Arcadia Investment Management reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Arcadia Investment Management sold 1,750 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $8K.
Arcadia Investment Management first reported a position in Insys Therapeutics, Inc. in Q2 2018 and held it in 4 quarters.
Arcadia Investment Management's Insys Therapeutics, Inc. position peaked at $18K in Q3 2018.
16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Arcadia Investment Management's 13F filing for Q2 2019, filed 23 Jul 2019.